Advertisement
Forex-Nachrichten
TSX Ends On Strong Note On Widespread Buying
After staying firm right through the day's session, the Canadian market ended on a strong note on Thursday thanks to impressive gains in technology, healthcare, energy and financials sectors.
RTTNews |
vor 851 Tagen
Win Streak May Continue For Malaysia Stock Market
The Malaysia stock market has finished higher in five straight sessions, gathering almost 30 points or 2 percent along the way. The Kuala Lumpur Composite Index now rests just above the 1,490-point plateau and it's tipped to open in the green again on Friday.
RTTNews
|
vor 851 Tagen
South Korea Inflation Data Due On Friday
South Korea will on Friday release December figures for consumer prices, highlighting a light day for Asia-Pacific economic activity.
RTTNews
|
vor 851 Tagen
Canadian Market Up Firmly In Positive Territory
The Canadian market is up firmly in positive territory around mid afternoon on Thursday with stocks from across several sectors posting strong gains.
RTTNews
|
vor 851 Tagen
Swiss Market Ends Modestly Higher
Despite opening on a negative note and staying weak till around mid afternoon, the Switzerland stock market ended on a fairly firm note on Thursday thanks to some strong buying at several frontline counters in the final hour of the session.
RTTNews
|
vor 851 Tagen
European Stocks Recover After Early Weakness, Close Broadly Higher
European stocks started off on a weak note on Thursday, but gained in strength as the session progressed and eventually ended on a positive note even as investors continued to weigh the possible impact of rising interest rates on global economic growth.
RTTNews
|
vor 851 Tagen
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
vor 851 Tagen
more news
U.S. Weekly Jobless Claims Inch Up Slightly More Than Expected
First-time claims for U.S. unemployment benefits rose by slightly more than expected in the week ended December 24th, according to a report released by the Labor Department on Thursday.
RTTNews
|
vor 851 Tagen
Elon Musk Attributes Twitter Outage To 'backend Server Architecture Changes'
Social media platform Twitter suffered a major outage on Wednesday morning that left thousands of global users unable to access some of its key features or even unable to login to their Twitter account on the web via desktops or laptops. Twitter's new owner and CEO Elon Musk attributed the outage to backend changes to speed up the micro-blogging platform.
RTTNews
|
vor 851 Tagen
Australian, NZ Dollars Drop As Risk Sentiment Sours
The Australian and NZ dollars weakened against their major counterparts in the European session on Thursday, as rising coronavirus infections in China triggered worries about the economic growth.
RTTNews
|
vor 851 Tagen
U.S. Weekly Jobless Claims Inch Up To 225,000
First-time claims for U.S. unemployment benefits rose by slightly more than expected in the week ended December 24th, according to a report released by the Labor Department on Thursday.
RTTNews
|
vor 851 Tagen
Bay Street Likely To See Mixed Start
Canadian shares are likely to open on a mixed note on Thursday, tracking commodity prices and somewhat sluggish European markets.
RTTNews
|
vor 851 Tagen
Viasat Awarded 5-Year $325 Mln IDIQ Contract By U.S. Special Operations Command
Communications company Viasat Inc. (VSAT) announced Thursday it was awarded an indefinite delivery, indefinite quantity (IDIQ) contract award worth up to $325 million over a five-year period to support the U.S. Special Operations Command (SOCOM). This sole-source IDIQ is an extension of a $350 million IDIQ contract awarded to Viasat in 2017.
RTTNews
|
vor 851 Tagen
Stay up to date!
Add Nachrichten to your browser
Add To Chrome
